Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Charlotte Elberling Almasi
  • Ib Jarle Christensen
  • Gunilla Høyer-Hansen
  • Keld Danø
  • Pappot, Helle
  • Hendrik Dienemann
  • Thomas Muley
To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.
OriginalsprogEngelsk
TidsskriftLung Cancer
Vol/bind74
Udgave nummer3
Sider (fra-til)510-515
ISSN0169-5002
DOI
StatusUdgivet - dec. 2011

ID: 40148396